- Home
- ABUS vs FMNB Comparison
ABUS vs FMNB Comparison
Compare ABUS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- FMNB
- Stock Information
- Founded
- ABUS 2005
- FMNB 1887
- Country
- ABUS United States
- FMNB United States
- Employees
- ABUS N/A
- FMNB N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- ABUS Health Care
- FMNB Finance
- Exchange
- ABUS Nasdaq
- FMNB Nasdaq
- Market Cap
- ABUS 611.0M
- FMNB 506.7M
- IPO Year
- ABUS N/A
- FMNB N/A
- Fundamental
- Price
- ABUS $3.37
- FMNB $14.12
- Analyst Decision
- ABUS Strong Buy
- FMNB Buy
- Analyst Count
- ABUS 3
- FMNB 2
- Target Price
- ABUS $5.67
- FMNB $15.50
- AVG Volume (30 Days)
- ABUS 636.5K
- FMNB 98.4K
- Earning Date
- ABUS 08-06-2025
- FMNB 07-23-2025
- Dividend Yield
- ABUS N/A
- FMNB 4.75%
- EPS Growth
- ABUS N/A
- FMNB N/A
- EPS
- ABUS N/A
- FMNB 1.34
- Revenue
- ABUS $15,416,000.00
- FMNB $169,441,000.00
- Revenue This Year
- ABUS $3.35
- FMNB $20.80
- Revenue Next Year
- ABUS N/A
- FMNB $8.33
- P/E Ratio
- ABUS N/A
- FMNB $10.68
- Revenue Growth
- ABUS 53.23
- FMNB 0.20
- 52 Week Low
- ABUS $2.71
- FMNB $11.58
- 52 Week High
- ABUS $4.73
- FMNB $16.29
- Technical
- Relative Strength Index (RSI)
- ABUS 54.05
- FMNB 55.44
- Support Level
- ABUS $3.33
- FMNB $13.35
- Resistance Level
- ABUS $3.45
- FMNB $14.53
- Average True Range (ATR)
- ABUS 0.12
- FMNB 0.30
- MACD
- ABUS 0.01
- FMNB 0.08
- Stochastic Oscillator
- ABUS 36.21
- FMNB 71.13
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.